Caringella AM

No ORCID on file · 6 papers in corpus
2025
Biomedicines ·doi:10.3390/biomedicines13102542

Background: Cancer treatments can damage the ovaries, with implications for fertility and reproductive lifespan. Therefore, a useful biomarker for fertility preservation counseling is needed, and anti-Müllerian hormone (AMH) measurement pro…

2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13071249

Background: In recent times, different novel GnRH-antagonist protocols with various combinations of gonadotropins and other molecules (e.g., aromatase inhibitors, selective estrogen receptor modulators) have been proposed for expected norma…

2023
BMC medical imaging ·doi:10.1186/s12880-023-01071-w

BackgroundThe usefulness of endometrium strain elastosonography (SE) for the evaluation of endometrial receptivity in women undergoing in vitro fertilization (IVF) remains controversial. The objective of this prospective, observational stud…

2022
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox11051019

Advanced maternal age impairs reproductive performance, influencing the quantity and the quality of oocytes. Mitochondria dysfunction seems to play a decisive role in conditioning the quality of the female gamete. Different in vitro and in …

2018
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-018-0405-3

BackgroundLetrozole is widely employed as ovulation induction agent in women with PCOS, but its use in mild stimulation (MS) protocols for IVF is limited. Aim of the present study was to evaluate the feasibility of a MS protocol with letroz…

article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.04.032

ObjectiveTo determine whether decreased estrogen receptor alpha (ER-α) expression in endometriotic lesions could be balanced by an increased expression of estrogen receptor-related receptors (ERRs). To evaluate whether ERR-α expression is i…